Erschienen in:
01.04.2014 | Research Article
The -786T > C polymorphism in the NOS3 gene is associated with increased cancer risk
verfasst von:
Yonggang Zhang, Qingyi Jia, Pei Xue, Yuqi Liu, Tianyuan Xiong, Jiqiao Yang, Chenxi Song, Qing He, Liang Du
Erschienen in:
Tumor Biology
|
Ausgabe 4/2014
Einloggen, um Zugang zu erhalten
Abstract
The -786T > C polymorphism in NOS3 gene may affect the DNA repair pathways and be associated with risk of cancer. However, the results of previous studies are inconsistent. The objective of this study is to investigate the association between the -786T > C polymorphism in NOS3 and risk of cancer by meta-analysis. We searched PubMed, Embase, CNKI, and Wanfang databases and the last search was updated on Sept. 20, 2013. Statistical analysis was performed using Revman4.2 and Stata10.0 software. A total of 9 case–control studies concerning 4,089 cases and 3,847 controls were included. The results suggested a significant association between the -786T > C polymorphism in NOS3 and cancer risk (CC vs. TT + CT; OR = 1.30, 95 % CI = 1.07–1.57, P = 0.007) in total analysis. In the subgroup analysis by ethnicity and cancer types, significant associations were found in the breast cancer subgroup (OR 1.51, 95 % CI 1.07–2.12; P = 0.02) and European subgroup (OR 1.26, 95 % CI 1.01–1.58; P = 0.04). The current meta-analysis suggested that the -786T > C polymorphisms in NOS3 may be a risk factor for cancer. In the future, more case–control studies are needed to validate our results.